Financials

  • Market Capitalization 1.49 B
  • Employee 140
  • Founded 2011
  • CEO N/A
  • Website www.absci.com
  • Headquarter Washington, United States
  • FIGI BBG011N54CJ8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-14.67
ratio cours/chiffre d'affaires
1 072.51

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2179
NVAX
Novavax, Inc. - Common Stock
9.26 USD+2.32%+4.28%+25.82%+25.30%1.53 B USD
2184
INVA
Innoviva, Inc. - Common Stock
20.97 USD+0.05%-0.47%0.00%+17.68%1.51 B USD
2195
TYRA
Tyra Biosciences, Inc. - Common Stock
24.94 USD-4.55%-4.04%-19.70%+73.92%1.49 B USD
2198
AVBP
ArriVent BioPharma, Inc. - Common Stock
30.17 USD-2.68%+3.96%+2.31%+55.92%1.49 B USD

Nouvelles